| Authors: |
Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Fernandez-Barrena MG; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Iguchi E; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., McCleary-Wheeler AL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Carr RM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Flores LF; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Vera RE; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Alfonse GW; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Hogenson TL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Vrabel AM; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Horn IP; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Koenig AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Safgren SL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Sigafoos AN; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Erkan M; Department of Surgery, Koc University School of Medicine, Istanbul, Turkey., Romecin-Duran PA; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Sarabia Gonzalez A; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Zhou B; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A., Javelaud D; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France., Marsaud V; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France., Graham RP; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, U.S.A., Mauviel A; Institut Curie, PSL Research University, INSERM U1021, CNRS UMR3347, Team 'TGF-ß and Oncogenesis', Equipe Labellisée LIGUE 2016, F-91400, Orsay, France.; Université Paris-Sud, F-91400, Orsay, France., Elsawa SF; Department of Molecular, Cellular and Biomedical Sciences, College of Life Sciences and Agriculture, University of New Hampshire, Durham, NH, U.S.A., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, U.S.A. |
